Clinical Trial Search

Primary: Internet Evaluation and Utility Questionnaire: Average Number of Log in to SHUTi Per Week During the Last 9 Weeks — 6 logins per week

Primary: Efficiency--Mean Cost of Care — 3933; 2761 US Dollars

Primary: Change in Patient-assessed Instantaneous Total Nasal Symptom Score (TNSS) From Baseline Compared to Placebo — -1.37; -1.04 score on a scale — p=0.028

Primary: Number of Participants With One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration — 0; 0; 0; 0 Participants

Primary: Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of Tirzepatide From Time Zero to Tlast (AUC[0-tlast]) — 78400; 81900; 98300; 81200…

Primary: Bell-Lysaker Emotion Recognition Task Total Score — 14.8; 16.00 score on a scale — p=.08

Primary: Primary Outcome — 33; 83 percentage of subjects

Primary: Number of Participants With Treatment-Emergent Adverse Events [Safety & Tolerability] — 1 Participants

Primary: Percentage of Participants With OINV Over 48 Hours — 8; 31; 4 Participants — p=<0.001

Primary: Blood Exposure — 1.9; 1.9 Number of Glove Pairs Used Per Razor Bla

Primary: Adverse Events of Participants Taking Patiromer in Lowering Serum Potassium Levels in End Stage Renal Disease (ESRD) Patients With Hyperkalemia Measured by…

Primary: Brief Pain Inventory-Short Form (BPI-SF) — 1.18; 2.84; 3.13 units on a scale

Primary: Pain Visual Analogue Scale (VAS) — 3.3; 2.3 units on a scale — p=<0.05

Primary: Standardized Validated Questionnaire Measuring Hearing Aid Sound Quality for First Study Set Worn, i.e. Study Set A for Arm A-B-A and Study Set B for Arm B-A-B — 7.16…

Primary: Percentage of Participants With Response — 0; 15; 65; 10 percentage of participants